Ipratropium bromide 0.2 MG/ML Inhalation Solution — RxCUI 836358
RxNorm drug concept · Semantic clinical drug
RxCUI 836358
Semantic clinical drug · SCD
● Current RxNorm concept 13 FDA products
30 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI836358
Official nameIpratropium bromide 0.2 MG/ML Inhalation Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asipratropium bromide 0.02 % Inhalation Solution; ipratropium bromide 0.5 MG per 2.5 ML Inhalation Solution
FDA products mapped13
Package NDCs mapped30
Reported Medicaid activity (SDUD)204,274 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ipratropium Nasal Spray: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It dries up a runny nose caused by the common cold or seasonal allergies. It won't help with stuffiness or sneezing, so you may still need something else for those.
- Spray it into each nostril, several times a day as your prescriber directs. Prime a new pump with seven sprays first. Keep it out of your eyes.
- For a cold, safety and effectiveness haven't been shown beyond four days. For seasonal allergies, they haven't been shown beyond three weeks. Check in with your doctor if symptoms...
- Nosebleeds, a dry nose, headache and a sore throat are the most common. Nasal dryness or nosebleeds were usually mild and often settled on their own. A moisturizing agent such as s...
🕸️ Concept Web — How Ipratropium bromide 0.2 MG/ML Inhalation Solutio... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ipratropium bromide 0.2 MG/ML Inhalation Solution
RxCUI 836358 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Ipratropium
7213IN -
Ipratropium bromide
203212PIN
-
Ipratropium
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ipratropium Inhalation Solution
2108449SCDF -
Ipratropium bromide Inhalation Solution
2646317SCDFP -
Ipratropium Inhalant Product
1158614SCDG -
Ipratropium bromide Inhalant Product
2663525SCDGP -
Inhalation Solution
346161DF -
Inhalant Product
1151123DFG
-
Ipratropium Inhalation Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ipratropium bromide 0.2 MG/ML
836357SCDC
-
Ipratropium bromide 0.2 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ipratropium bromide 0.2 MG/ML
SCDC · 836357 -
Ipratropium Inhalation Solution
SCDF · 2108449 -
Ipratropium bromide Inhalation Solution
SCDFP · 2646317 -
Ipratropium Inhalant Product
SCDG · 1158614 -
Ipratropium bromide Inhalant Product
SCDGP · 2663525
📦 FDA Products & Package NDCs
13 products · 30 package NDCs
30 package NDCs map to RxCUI 836358 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-7970-52 | 1 POUCH in 1 CARTON (0378-7970-52) / 25 AMPULE in 1 POUCH (... | Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 2010-11-09 |
| 00378-7970-55 | 30 POUCH in 1 CARTON (0378-7970-55) / 1 AMPULE in 1 POUCH (... | Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 2010-11-09 |
| 00378-7970-91 | 2 POUCH in 1 CARTON (0378-7970-91) / 30 AMPULE in 1 POUCH /... | Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 2010-11-09 |
| 00378-7970-93 | 1 POUCH in 1 CARTON (0378-7970-93) / 30 AMPULE in 1 POUCH (... | Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 2010-11-09 |
| 00487-9801-01 | 30 POUCH in 1 CARTON (0487-9801-01) / 1 VIAL, SINGLE-DOSE i... | Ipratropium Bromide | Nephron Pharmaceuticals Corporation | 2001-09-27 |
| 00487-9801-02 | 30 BAG in 1 BOX (0487-9801-02) / 1 POUCH in 1 BAG / 1 VIAL,... | Ipratropium Bromide | Nephron Pharmaceuticals Corporation | 2001-09-27 |
| 00487-9801-25 | 1 POUCH in 1 CARTON (0487-9801-25) / 25 VIAL, SINGLE-DOSE i... | Ipratropium Bromide | Nephron Pharmaceuticals Corporation | 2001-09-27 |
| 00487-9801-30 | 1 POUCH in 1 CARTON (0487-9801-30) / 30 VIAL, SINGLE-DOSE i... | Ipratropium Bromide | Nephron Pharmaceuticals Corporation | 2001-09-27 |
| 00487-9801-60 | 2 POUCH in 1 CARTON (0487-9801-60) / 30 VIAL, SINGLE-DOSE i... | Ipratropium Bromide | Nephron Pharmaceuticals Corporation | 2001-09-27 |
| 47335-0706-49 | 5 POUCH in 1 CARTON (47335-706-49) / 5 VIAL in 1 POUCH (473... | Ipratropium Bromide | Sun Pharmaceutical Industries, Inc. | 2020-02-04 |
| 47335-0706-52 | 6 POUCH in 1 CARTON (47335-706-52) / 5 VIAL in 1 POUCH / 2.... | Ipratropium Bromide | Sun Pharmaceutical Industries, Inc. | 2020-02-04 |
| 47335-0706-54 | 12 POUCH in 1 CARTON (47335-706-54) / 5 VIAL in 1 POUCH / 2... | Ipratropium Bromide | Sun Pharmaceutical Industries, Inc. | 2020-02-04 |
| 50090-0668-00 | 1 POUCH in 1 CARTON (50090-0668-0) / 25 mL in 1 POUCH | Ipratropium Bromide | A-S Medication Solutions | 2014-11-28 |
| 50090-6373-00 | 25 POUCH in 1 CARTON (50090-6373-0) / 2.5 mL in 1 POUCH | Ipratropium Bromide | A-S Medication Solutions | 2023-02-14 |
| 55154-2134-05 | 5 POUCH in 1 BAG (55154-2134-5) / 1 AMPULE in 1 POUCH / 2.5... | Ipratropium Bromide | Cardinal Health 107, LLC | 2018-12-26 |
| 60687-0394-83 | 30 POUCH in 1 CARTON (60687-394-83) / 1 AMPULE in 1 POUCH (... | Ipratropium Bromide | American Health Packaging | 2019-01-07 |
| 62135-0830-84 | 6 POUCH in 1 CARTON (62135-830-84) / 5 VIAL in 1 POUCH / 2.... | Ipratropium Bromide | Chartwell RX, LLC | 2024-01-25 |
| 64980-0640-02 | 1 POUCH in 1 CARTON (64980-640-02) / 25 VIAL, SINGLE-DOSE i... | Ipratropium Bromide | Rising Pharma Holdings, Inc. | 2025-04-25 |
| 64980-0640-03 | 1 POUCH in 1 CARTON (64980-640-03) / 30 VIAL, SINGLE-DOSE i... | Ipratropium Bromide | Rising Pharma Holdings, Inc. | 2025-04-25 |
| 64980-0640-06 | 2 POUCH in 1 CARTON (64980-640-06) / 30 VIAL, SINGLE-DOSE i... | Ipratropium Bromide | Rising Pharma Holdings, Inc. | 2025-04-25 |
| 65862-0905-03 | 30 POUCH in 1 CARTON (65862-905-03) / 1 VIAL, SINGLE-DOSE i... | Ipratropium bromide | Aurobindo Pharma Limited | 2016-10-27 |
| 65862-0905-25 | 1 POUCH in 1 CARTON (65862-905-25) / 25 VIAL, SINGLE-DOSE i... | Ipratropium bromide | Aurobindo Pharma Limited | 2016-10-27 |
| 65862-0905-30 | 1 POUCH in 1 CARTON (65862-905-30) / 30 VIAL, SINGLE-DOSE i... | Ipratropium bromide | Aurobindo Pharma Limited | 2016-10-27 |
| 65862-0905-60 | 2 POUCH in 1 CARTON (65862-905-60) / 30 VIAL, SINGLE-DOSE i... | Ipratropium bromide | Aurobindo Pharma Limited | 2016-10-27 |
| 67296-2246-01 | 1 POUCH in 1 CARTON (67296-2246-1) / 25 AMPULE in 1 POUCH /... | Ipratropium Bromide | Redpharm Drug | 2011-11-21 |
| 68071-3769-02 | 25 AMPULE in 1 POUCH (68071-3769-2) / 2.5 mL in 1 AMPULE | Ipratropium Bromide | NuCare Pharmaceuticals, Inc. | 2025-01-13 |
| 76204-0100-01 | 30 POUCH in 1 CARTON (76204-100-01) / 1 AMPULE in 1 POUCH /... | Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 2011-11-21 |
| 76204-0100-25 | 1 POUCH in 1 CARTON (76204-100-25) / 25 AMPULE in 1 POUCH /... | Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 2011-11-21 |
| 76204-0100-30 | 1 POUCH in 1 CARTON (76204-100-30) / 30 AMPULE in 1 POUCH /... | Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 2011-11-21 |
| 76204-0100-60 | 2 POUCH in 1 CARTON (76204-100-60) / 30 AMPULE in 1 POUCH /... | Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 2011-11-21 |
Observed labelers:
Nephron Pharmaceuticals Corporation (5) ·
Aurobindo Pharma Limited (4) ·
Mylan Pharmaceuticals Inc. (4) ·
Ritedose Pharmaceuticals, LLC (4) ·
Rising Pharma Holdings, Inc. (3) ·
Sun Pharmaceutical Industries, Inc. (3)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.1128
Range $0.0950–$0.1147
· middle 50% $0.1080–$0.1147
· 20 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7644 | Ipratropium bromide non-comp | 22 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.